{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T05:10:34Z","timestamp":1788844234477,"version":"build-2803163510"},"reference-count":65,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Fatigue is a multidimensional syndrome involving the cognitive and physical domains, and NAD\n                      <jats:sup>+<\/jats:sup>\n                      -dependent biological energy dysfunction is considered a key mechanism. This study aimed to compare the efficacy of niacinamide adenine dinucleotide (NAD\n                      <jats:sup>+<\/jats:sup>\n                      ) precursors in cognitive, motor and perceived fatigue domains using a domain-based network meta-analysis (NMA).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A systematic review and NMA were conducted on randomized controlled trials (RCTs) according to the PRISMA-NMA guidelines (PROSPERO: CRD420251237193). Including adults who receive NAD\n                      <jats:sup>+<\/jats:sup>\n                      precursors [niacinamide nucleotide (NR), niacinamide mononucleotide (NMN), niacinamide adenine dinucleotide (NADH) and niacinamide (NAM)]. The outcomes were categorized within the domain-based fatigue framework, divided into perceived fatigue, cognitive performance and exercise performance (endurance and strength), with functional outcomes comprising quality of life (QoL) and sleep. The standardized mean difference (SMD) is summarized, and the surface under the cumulative ranking curve (SUCRA) was calculated.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 27 studies (\n                      <jats:italic>n<\/jats:italic>\n                      \u202f=\u202f1,599) were synthesized, including 25 RCTs and 2 quasi-experimental tests. The influence of the NAD\n                      <jats:sup>+<\/jats:sup>\n                      precursor is specific to the domain. No precursor can significantly improve perceived fatigue or sleep quality. In contrast, NMN showed dose-dependent enhancement in endurance (medium dose: SMD\u202f=\u202f0.66, 95% CI 0.09\u20131.23; high dose: SMD\u202f=\u202f1.02, 95% CI 0.43\u20131.60), while neuromuscular strength remained unchanged. For cognitive performance, NADH produced the strongest improvement (SMD\u202f=\u202f1.50, 95% CI 0.82\u20132.19), especially in cognitive impairment cohorts, although this finding was sensitive to influential studies. Moderate improvement in the quality of life was observed, mainly NMN (high dose: SMD\u202f=\u202f0.56, 95% CI 0.14\u20130.98; low dose: SMD\u202f=\u202f0.45, 95% CI 0.11\u20130.78).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      NAD\n                      <jats:sup>+<\/jats:sup>\n                      precursor supplementation exerts a selective impact on fatigue-related outcomes. This study emphasizes the domain-based NMA framework to unravel heterogeneous fatigue outcomes, in which NAD\n                      <jats:sup>+<\/jats:sup>\n                      precursor prioritizes improving endurance-related performance. But with limited translation to subjective fatigue and neuromuscular strength, it supports a precision-based approach of NAD\n                      <jats:sup>+<\/jats:sup>\n                      supplements that considers outcome type, dosage, and population characteristics.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic review registration<\/jats:title>\n                    <jats:p>\n                      PROSPERO. CRD420251237193.\n                      <jats:ext-link>https:\/\/www.crd.york.ac.uk\/PROSPERO\/view\/CRD420251237193<\/jats:ext-link>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fnut.2026.1890335","type":"journal-article","created":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T04:26:19Z","timestamp":1788841579000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Domain-specific effects of NAD+ precursors on fatigue and functional performance: a systematic review and network meta-analysis"],"prefix":"10.3389","volume":"13","author":[{"given":"Yixuan","family":"Gao","sequence":"first","affiliation":[{"name":"School of Sport Science, Beijing Sport University","place":["Beijing, China"]},{"name":"Key Laboratory of Sports and Physical Health of Ministry of Education, Beijing Sport University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengnian","family":"Li","sequence":"additional","affiliation":[{"name":"School of Strength and Conditioning Training, Beijing Sport University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjun","family":"Guan","sequence":"additional","affiliation":[{"name":"School of Strength and Conditioning Training, Beijing Sport University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yikun","family":"Yin","sequence":"additional","affiliation":[{"name":"School of Sport Science, Beijing Sport University","place":["Beijing, China"]},{"name":"Key Laboratory of Sports and Physical Health of Ministry of Education, Beijing Sport University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianghao","family":"Kong","sequence":"additional","affiliation":[{"name":"School of Sport Science, Beijing Sport University","place":["Beijing, China"]},{"name":"Key Laboratory of Sports and Physical Health of Ministry of Education, Beijing Sport University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Yu","sequence":"additional","affiliation":[{"name":"School of Sport Science, Beijing Sport University","place":["Beijing, China"]},{"name":"Academic Affairs Office, Beijing Sport University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,8]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s40279-022-01748-2","article-title":"Fatigue and human performance: an updated framework","volume":"53","author":"Behrens","year":"2023","journal-title":"Sports Med"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"e2426874122","DOI":"10.1073\/pnas.2426874122","article-title":"Patient-reported treatment outcomes in ME\/CFS and long COVID","volume":"122","author":"Eckey","year":"2025","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1016\/j.celrep.2019.07.043","article-title":"Nicotinamide riboside augments the aged human skeletal muscle NAD(+) metabolome and induces transcriptomic and anti-inflammatory signatures","volume":"28","author":"Elhassan","year":"2019","journal-title":"Cell Rep"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12967-019-02196-9","article-title":"Systematic review of randomized controlled trials for chronic fatigue syndrome\/myalgic encephalomyelitis (CFS\/ME)","volume":"18","author":"Kim","year":"2020","journal-title":"J Transl Med"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1097\/mco.0000000000000691","article-title":"Can nicotinamide riboside protect against cognitive impairment?","volume":"23","author":"Braidy","year":"2020","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.cmet.2024.10.021","article-title":"Mitochondrial calcium uptake declines during aging and is directly activated by oleuropein to boost energy metabolism and skeletal muscle performance","volume":"37","author":"Gherardi","year":"2025","journal-title":"Cell Metab"},{"key":"ref7","first-page":"18","article-title":"Mitochondrial dysfunction and chronic disease: treatment with natural supplements","volume":"20","author":"Nicolson","year":"2014","journal-title":"Altern Ther Health Med"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1152\/physiol.00056.2024","article-title":"Mitochondrial dysfunction in Myalgic encephalomyelitis\/chronic fatigue syndrome","volume":"40","author":"Syed","year":"2025","journal-title":"Physiology (Bethesda)"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"738","DOI":"10.3390\/cells8070738","article-title":"A narrative review of Cancer-related fatigue (CRF) and its possible pathogenesis","volume":"8","author":"Yang","year":"2019","journal-title":"Cells"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/s41580-020-00313-x","article-title":"NAD(+) metabolism and its roles in cellular processes during ageing","volume":"22","author":"Covarrubias","year":"2021","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.tcb.2014.04.002","article-title":"NAD+ and sirtuins in aging and disease","volume":"24","author":"Imai","year":"2014","journal-title":"Trends Cell Biol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"112174","DOI":"10.1016\/j.mad.2026.112174","article-title":"NAD+ as a central metabolic hub regulating the hallmarks of aging: mechanisms and therapeutic implications","volume":"231","author":"Pei","year":"2026","journal-title":"Mech Ageing Dev"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1046\/j.1563-258x.2002.02072.x","article-title":"Stabilized NADH (ENADA) improves jet lag-induced cognitive performance deficit","volume":"152","author":"Birkmayer","year":"1946","journal-title":"Wien Med Wochenschr"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S1081-1206(10)62595-1","article-title":"Therapeutic effects of oral NADH on the symptoms of patients with chronic fatigue syndrome","volume":"82","author":"Forsyth","year":"1999","journal-title":"Ann Allergy Asthma Immunol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.cmet.2012.04.022","article-title":"The NAD(+) precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity","volume":"15","author":"Cant\u00f3","year":"2012","journal-title":"Cell Metab"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s42255-018-0009-4","article-title":"Slc12a8 is a nicotinamide mononucleotide transporter","volume":"1","author":"Grozio","year":"2019","journal-title":"Nat Metab"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1146\/annurev.nutr.28.061807.155443","article-title":"Nicotinic acid, nicotinamide, and nicotinamide riboside: a molecular evaluation of NAD+ precursor vitamins in human nutrition","volume":"28","author":"Bogan","year":"2008","journal-title":"Annu Rev Nutr"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3390\/nu15092154","article-title":"Nutrient therapy for the improvement of fatigue symptoms","volume":"15","author":"Barnish","year":"2023","journal-title":"Nutrients"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1664734","DOI":"10.3389\/fneur.2025.1664734","article-title":"Tired minds, normal scores: rethinking cognitive fatigue in multiple sclerosis","volume":"16","author":"Spinetti","year":"2025","journal-title":"Front Neurol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.joim.2025.04.008","article-title":"Effects of dietary supplements on patients with osteoarthritis: a systematic review and network meta-analysis","volume":"23","author":"Chen","year":"2025","journal-title":"J Integr Med"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"8303","DOI":"10.3390\/jcm14238303","article-title":"Validity and reliability of the six-minute walking test compared to cardiopulmonary exercise test in individuals with heart failure systematic review and Meta-analysis","volume":"14","author":"Pepera","year":"2025","journal-title":"J Clin Med"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s43657-023-00115-z","article-title":"A proactive intervention study in metabolic syndrome high-risk populations using phenome-based actionable P4 medicine strategy","volume":"4","author":"Huang","year":"2024","journal-title":"Phenomics"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"777","DOI":"10.7326\/m14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations","volume":"162","author":"Hutton","year":"2015","journal-title":"Ann Intern Med"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1212\/WNL.0b013e31827f07be","article-title":"Fatigue and fatigability in neurologic illnesses: proposal for a unified taxonomy","volume":"80","author":"Kluger","year":"2013","journal-title":"Neurology"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1172\/jci.insight.167274","article-title":"Randomized crossover clinical trial of coenzyme Q10 and nicotinamide riboside in chronic kidney disease","volume":"8","author":"Ahmadi","year":"2023","journal-title":"JCI Insight"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.rce.2009.09.015","article-title":"Nicotinamide adenine dinucleotide (NADH) in patients with chronic fatigue syndrome","volume":"210","author":"Alegre","year":"2010","journal-title":"Rev Clin Esp"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"7793","DOI":"10.1038\/s41467-023-43514-6","article-title":"NR-SAFE: a randomized, double-blind safety trial of high dose nicotinamide riboside in Parkinson's disease","volume":"14","author":"Berven","year":"2023","journal-title":"Nat Commun"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.cmet.2022.02.001","article-title":"The NADPARK study: a randomized phase I trial of nicotinamide riboside supplementation in Parkinson's disease","volume":"34","author":"Brakedal","year":"2022","journal-title":"Cell Metab"},{"key":"ref29","first-page":"27","article-title":"Treatment of Alzheimer's disease with stabilized oral nicotinamide adenine dinucleotide: a randomized, double-blind study","volume":"30","author":"Demarin","year":"2004","journal-title":"Drugs Exp Clin Res"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s00394-019-01919-4","article-title":"Acute nicotinamide riboside supplementation improves redox homeostasis and exercise performance in old individuals: a double-blind cross-over study","volume":"59","author":"Dolopikou","year":"2020","journal-title":"Eur J Nutr"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1038\/s41467-018-03421-7","article-title":"Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD(+) in healthy middle-aged and older adults","volume":"9","author":"Martens","year":"2018","journal-title":"Nat Commun"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"5046","DOI":"10.1038\/s41467-024-49092-5","article-title":"Nicotinamide riboside for peripheral artery disease: the NICE randomized clinical trial","volume":"15","author":"McDermott","year":"2024","journal-title":"Nat Commun"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1080\/02640410701474200","article-title":"Effects of nicotinamide adenine dinucleotide hydride on physical and mental performance","volume":"26","author":"Mero","year":"2008","journal-title":"J Sports Sci"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s11357-023-00999-9","article-title":"A randomized placebo-controlled trial of nicotinamide riboside in older adults with mild cognitive impairment","volume":"46","author":"Orr","year":"2024","journal-title":"GeroScience"},{"key":"ref35","first-page":"89","article-title":"Comparison of oral nicotinamide adenine dinucleotide (NADH) versus conventional therapy for chronic fatigue syndrome","volume":"23","author":"Santaella","year":"2004","journal-title":"P R Health Sci J"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/ggi.14513","article-title":"Effects of nicotinamide mononucleotide on older patients with diabetes and impaired physical performance: a prospective, placebo-controlled, double-blind study","volume":"23","author":"Akasaka","year":"2023","journal-title":"Geriatr Gerontol Int"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"e210152","DOI":"10.1212\/wnl.0000000000210152","article-title":"Phase 2A proof-of-concept double-blind, randomized, placebo-controlled trial of nicotinamide in early Alzheimer disease","volume":"104","author":"Grill","year":"2025","journal-title":"Neurology"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"851698","DOI":"10.3389\/fragi.2022.851698","article-title":"A multicentre, randomised, double blind, parallel design, placebo controlled study to evaluate the efficacy and safety of Uthever (NMN supplement), an orally administered supplementation in middle aged and older adults","volume":"3","author":"Huang","year":"2022","journal-title":"Front Aging"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41514-022-00084-z","article-title":"Chronic nicotinamide mononucleotide supplementation elevates blood nicotinamide adenine dinucleotide levels and alters muscle function in healthy older men","volume":"8","author":"Igarashi","year":"2022","journal-title":"NPJ Aging"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"755","DOI":"10.3390\/nu14040755","article-title":"Effect of 12-week intake of nicotinamide mononucleotide on sleep quality, fatigue, and physical performance in older Japanese adults: a randomized, double-blind placebo-controlled study","volume":"14","author":"Kim","year":"2022","journal-title":"Nutrients"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"111917","DOI":"10.1016\/j.mad.2024.111917","article-title":"Towards personalized nicotinamide mononucleotide (NMN) supplementation: nicotinamide adenine dinucleotide (NAD) concentration","volume":"218","author":"Kuerec","year":"2024","journal-title":"Mech Ageing Dev"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"4671","DOI":"10.1007\/s11357-024-01204-1","article-title":"Ingestion of \u03b2-nicotinamide mononucleotide increased blood NAD levels, maintained walking speed, and improved sleep quality in older adults in a double-blind randomized, placebo-controlled study","volume":"46","author":"Morifuji","year":"2024","journal-title":"GeroScience"},{"key":"ref43","year":"2018"},{"key":"ref44","year":"2019"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1038\/s42255-025-01290-1","article-title":"Nicotinamide modulates gut microbial metabolic potential and accelerates recovery in mild-to-moderate COVID-19","volume":"7","author":"Schreiber","year":"2025","journal-title":"Nat Metab"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s11357-022-00705-1","article-title":"The efficacy and safety of \u03b2-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial","volume":"45","author":"Yi","year":"2023","journal-title":"GeroScience"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"e70023","DOI":"10.1002\/trc2.70023","article-title":"Cognitive and Alzheimer's disease biomarker effects of oral nicotinamide riboside (NR) supplementation in older adults with subjective cognitive decline and mild cognitive impairment","volume":"11","author":"Wu","year":"2025","journal-title":"Alzheimers Dement Transl Res Clin Interv"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"103633","DOI":"10.1016\/j.eclinm.2025.103633","article-title":"Effects of nicotinamide riboside on NAD+ levels, cognition, and symptom recovery in long-COVID: a randomized controlled trial","volume":"89","author":"Wu","year":"2025","journal-title":"EClinicalMedicine"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/s42255-025-01421-8","article-title":"The differential impact of three different NAD+ boosters on circulatory NAD and microbial metabolism in humans","volume":"8","author":"Christen","year":"2026","journal-title":"Nat Metab"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1038\/s42255-025-01387-7","article-title":"NAD+ precursor supplementation in human ageing: clinical evidence and challenges","volume":"7","author":"Vinten","year":"2025","journal-title":"Nat Metab"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12970-021-00442-4","article-title":"Nicotinamide mononucleotide supplementation enhances aerobic capacity in amateur runners: a randomized, double-blind study","volume":"18","author":"Liao","year":"2021","journal-title":"J Int Soc Sports Nutr"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1002\/crt2.56","article-title":"Effects of nicotinamide adenine dinucleotide precursors on measures of physical performance and physical frailty: a systematic review","volume":"7","author":"Barker","year":"2022","journal-title":"JCSM Clin Rep"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/s41514-025-00192-6","article-title":"NAD world 3.0: the importance of the NMN transporter and eNAMPT in mammalian aging and longevity control","volume":"11","author":"Imai","year":"2025","journal-title":"NPJ Aging"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1126\/sciadv.add5163","article-title":"Nicotinamide riboside improves muscle mitochondrial biogenesis, satellite cell differentiation, and gut microbiota in a twin study","volume":"9","author":"Lapatto","year":"2023","journal-title":"Sci Adv"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"16456","DOI":"10.1074\/jbc.M501485200","article-title":"SIRT1 functionally interacts with the metabolic regulator and transcriptional coactivator PGC-1{alpha}","volume":"280","author":"Nemoto","year":"2005","journal-title":"J Biol Chem"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/s41582-025-01153-z","article-title":"Fatigue: a common but poorly understood symptom in neurological and non-neurological diseases","volume":"21","author":"Penner","year":"2025","journal-title":"Nat Rev Neurol"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"119881","DOI":"10.1016\/j.jep.2025.119881","article-title":"Shenqi Funeng Xingnao prescription alleviates exercise-induced fatigue by regulating the HIF-1\/FoxO signaling pathway","volume":"348","author":"Xu","year":"2025","journal-title":"J Ethnopharmacol"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"121035","DOI":"10.1016\/j.jep.2025.121035","article-title":"Shenqi funeng xingnao prescription regulated the TNF\/NOD\u2013like receptor signaling pathway and brain-gut axis dysfunction caused by exercise-induced fatigue","volume":"358","author":"Xu","year":"2026","journal-title":"J Ethnopharmacol"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"kkae007","DOI":"10.1093\/psyrad\/kkae007","article-title":"Microbiota-gut-brain axis: the mediator of exercise and brain health","volume":"4","author":"Kang","year":"2024","journal-title":"Psychoradiology"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"1424926","DOI":"10.3389\/fmed.2024.1424926","article-title":"Unraveling the fatigue puzzle: insights into the pathogenesis and management of IBD-related fatigue including the role of the gut-brain axis","volume":"11","author":"Truyens","year":"2024","journal-title":"Front Med (Lausanne)"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"e65961","DOI":"10.7759\/cureus.65961","article-title":"Improved physical performance parameters in patients taking nicotinamide mononucleotide (NMN): a systematic review of randomized control trials","volume":"16","author":"Wen","year":"2024","journal-title":"Cureus"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"E417","DOI":"10.1152\/ajpendo.00242.2023","article-title":"Evaluation of safety and effectiveness of NAD in different clinical conditions: a systematic review","volume":"326","author":"Gindri","year":"2024","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1093\/ajcn\/nqy132","article-title":"A randomized placebo-controlled clinical trial of nicotinamide riboside in obese men: safety, insulin-sensitivity, and lipid-mobilizing effects","volume":"108","author":"Dollerup","year":"2018","journal-title":"Am J Clin Nutr"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1126\/science.abe9985","article-title":"Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women","volume":"372","author":"Yoshino","year":"2021","journal-title":"Science"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.cmet.2018.03.018","article-title":"Quantitative analysis of NAD synthesis-breakdown fluxes","volume":"27","author":"Liu","year":"2018","journal-title":"Cell Metab"}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2026.1890335\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T04:26:21Z","timestamp":1788841581000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2026.1890335\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,8]]},"references-count":65,"alternative-id":["10.3389\/fnut.2026.1890335"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2026.1890335","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,8]]},"article-number":"1890335"}}